会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明申请
    • Steroid kit and foamable composition and uses thereof
    • 类固醇试剂盒和可发泡组合物及其用途
    • US20060018937A1
    • 2006-01-26
    • US11114410
    • 2005-04-26
    • Doron FriedmanAlex BesonovDov TamarkinMeir Eini
    • Doron FriedmanAlex BesonovDov TamarkinMeir Eini
    • A61K8/02
    • A61K9/122A61K8/046A61K8/671A61K9/0014A61K31/07A61K31/203A61K31/56A61K31/568A61K31/573A61Q19/00
    • A composition and therapeutic kit including an aerosol packaging assembly including a container accommodating a pressurized product and an outlet capable of releasing a foamable composition, including a steroid as a foam. The pressurized product includes a foamable composition including: a container accommodating a pressurized product; and an outlet capable of releasing the pressurized product as a foam; wherein the pressurized product comprises a foamable composition including: i. a steroid; ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight; iii. a surface-active agent; iv. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; v. water; and vi. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition. The composition further may include a therapeutically active foam adjuvant, selected from the group consisting of a fatty alcohol, a fatty acid, a hydroxyl fatty acid; and mixtures thereof.
    • 一种组合物和治疗试剂盒,其包括气溶胶包装组件,其包括容纳加压产品的容器和能够释放可发泡组合物的出口,其包括类固醇作为泡沫。 加压产品包括可发泡组合物,其包括:容纳加压产品的容器; 以及能够释放作为泡沫的加压产品的出口; 其中所述加压产品包括可发泡组合物,其包含:i。 类固醇 ii。 选自浓度为约2%至约50%重​​量的至少一种选自疏水性有机载体,极性溶剂,软化剂及其混合物的有机载体; iii。 表面活性剂; iv。 约0.01重量%至约5重量%的至少一种选自生物粘附剂,胶凝剂,成膜剂和相变剂的聚合物添加剂; v。水 和vi。 液化或压缩气体推进剂的浓度为总组合物重量的约3%至约25%。 组合物还可以包括治疗活性的泡沫佐剂,其选自脂肪醇,脂肪酸,羟基脂肪酸; 及其混合物。
    • 74. 发明申请
    • Kit and composition of imidazole with enhanced bioavailability
    • 具有增强的生物利用度的咪唑的试剂盒和组成
    • US20050186142A1
    • 2005-08-25
    • US11041921
    • 2005-01-24
    • Dov TamarkinDoron FriedmanMeir Eini
    • Dov TamarkinDoron FriedmanMeir Eini
    • A61K9/00A61L9/04A61M11/00
    • A61M11/04A01N25/16A61K9/0014A61K9/107A61K9/122A61K31/41A61K31/415A61K31/4164A61K31/496A61K47/14A61K47/26A61K47/36A61K47/38
    • A composition and therapeutic kit provide a therapeutic azole with increased solubility. The kit includes an aerosol packaging assembly containing a container accommodating a pressurized product and an outlet capable of releasing the pressurized product as a foam. The pressurized product includes a foamable composition including: i. a therapeutic azole, wherein the solubility of the azole in the composition before foaming is less than the solubility of the azole in the composition after foaming; ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a co-solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight; iii. a surface-active agent; iv. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; v. water; and vi. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
    • 组合物和治疗试剂盒提供治疗性唑,溶解度增加。 该试剂盒包括含有容纳加压产品的容器和能够释放作为泡沫的加压产品的出口的气溶胶包装组件。 加压产品包括可发泡组合物,其包括:i。 治疗性唑,其中唑在发泡前在组合物中的溶解度小于发泡后唑类在组合物中的溶解度; ii。 选自浓度为约2重量%至约50重量%的至少一种选自疏水性有机载体,共溶剂,软化剂及其混合物的有机载体; iii。 表面活性剂; iv。 约0.01重量%至约5重量%的至少一种选自生物粘附剂,胶凝剂,成膜剂和相变剂的聚合物添加剂; v。水 和vi。 液化或压缩气体推进剂的浓度为总组合物重量的约3%至约25%。